AI chatbots offered mixed benefits and drawbacks for people using them to seek information on dermatologic conditions, ...

CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the two pivotal Phase 3 randomized, ...

In a surprising new study, scientists from Ewha Woman’s University have found a possible link between common blood pressure medicines and psoriasis. They looked at information from 13 different ...

Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 ...

Shares of Takeda Pharmaceuticals rose after the Japanese pharmaceutical major announced positive results from clinical trials of its new treatment for plaque psoriasis. The stock climbed 4.3% in early ...

Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA® , a white uniform cream containing 0.

A real-world analysis reveals that tildrakizumab is highly effective and safe in patients with moderate-to-severe plaque ...

Psoriasis is not just something that affects how you look. It is a full-body disease that can affect your overall health, ...

Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...

A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular ...

Learn how to pick the best cleansers when you have psoriasis, with expert advice and details on what ingredients to seek out — and which to avoid.